Tomer Berkovitz

Alcobra Ltd. engages in the research, development, and market of pharmaceutical productsfor the treatment of central nervous system disorders and cognitive dysfunctions. Its portfolio includes Metadoxine Extended Release to treat Attention Deficit Hyperactivity Disorder and Fragile X Syndrome. The company was founded by Ehud Moshe Gilboa and Dalia Megiddo on February 7, 2008 and is headquartered in Tel Aviv, Israel.

JPMorgan Chase Bank, NA provides commercial banking services. It offers investment banking, merchant services, and institutional asset management services. The company is headquartered in New York, NY.

aMoon Ventures Y Sh Ltd (aMoon Ventures) is an venture capital firm founded in 2016 by Marius Nacht and Dr. Yair Schindel. The firm is headquartered in Israel.

Mapi-Pharma Ltd. is a clinical stage pharmaceutical company engaging in the development of extended-release versions of existing commercial generic drugs. Its products include injections for treatment of multiple sclerosis, active pharmaceutical ingredient, and oral drugs for the treatment of neuropathic pain. The company was founded by Ehud Marom in 2008 and is headquartered in Ness Ziona, Israel.

PrognomIQ, Inc. operates as a healthcare company, which engages in the development and commercialization of multi-omics human tests for cancer and other complex diseases. It aims to leverage Seer’s Proteograph in addition to genomics and metabolomics technologies, to develop multi-omics products to improve human health. The company is headquartered in Redwood City, CA.

Zebra Medical Vision Ltd. engages in the development of medical imaging insights platform. The firm's solution enables researchers to develop imaging algorithms and insights based on large scale datasets and advanced processing power. The company was founded by Eyal Toledano, Eyal Gura, and Elad Benjamin in 2014 and is headquartered in Shfayim, Israel.

aMoon Fund invests in companies located in Israel. The fund target companies operating in the fields of health tech & life sciences. It provides financing for early and later stage capital requirements with an investment size USD 10 million to 30 million.